FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology

• Elizabeth S. Russell,
• Elodie Aubrun,
• Daniela C. Moga,
• Sandra Guedes,
• Wendy Camelo Castillo,
• Janet R. Hardy,
• J. Alexander Cole,
• Oladayo Jagun

Affiliations

Elizabeth S. Russell

ORCiD

Merck & Co., Inc., Rahway, NJ, USA

Elodie Aubrun

Novartis Pharma AG, Basel, Switzerland

Daniela C. Moga

University of Kentucky, College of Pharmacy, Lexington, KY, USA

Sandra Guedes

Ferring Pharmaceuticals A/S, Copenhagen, Denmark

Wendy Camelo Castillo

University of Maryland School of Pharmacy, Baltimore, MD, USA

Janet R. Hardy

Biohaven Pharmaceuticals Holding Company Ltd., New Haven, CT, USA

J. Alexander Cole

Alexion - AstraZeneca Rare Disease, Boston, MA, USA

Oladayo Jagun

Pfizer Inc., New York, NY, USA